Topics

Companies Related to "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" [Most Relevant Company Matches] [Advanced Search Results] RSS

05:12 EST 29th February 2020 | BioPortfolio

Here are the most relevant search results for "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" found in our extensive corporate database of over 50,000 company records.

Showing "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment" Companies 1–25 of 5,400+

Relevant

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. In addition to AR-67, Arno's lead clinical compound is AR-12, a potentially first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces autophagy and the endoplasmi...


Enzyvant

Enzyvant, a wholly owned subsidiary of Roivant Sciences, is a biotechnology company focused on developing transformative therapies for patients with rare diseases. Enzyvant leverages the Roivant platform to develop therapies that address high unmet medical needs while driving greater efficiency in research, clinical development, and commercialization. The ...

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...


Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Priority Health

Priority Health is an award-winning health benefits company recognized for its innovative solutions that improve health, lower costs and increase patient satisfaction. It provides more than 600,000 people with a broad portfolio of products, including commercial and government health plans. As a nonprofit, Priority Health has a mission to make health care o...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

Elusys Therapeutics, Inc

Elusys Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using proprietary Heteropolymer (HP) Antibodies for the treatment of infectious disease. The Company’s most advanced product, Anthim™, a treatment for Anthrax infection, has entered Phase I human safety studies. Anthim represents a near-term revenue opportu...

Catalyst Pharmaceutical Partners

Catalyst is a specialty pharmaceutical company of Coral Gables, Florida, that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction. Catalyst is developing vigabatrin (designated CPP-109 by Catalyst) for the treatment of addiction to cocaine, methamphetamine and other addictive substances. The National Institute on Drug Abuse has stated that f...

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. (CAPR), a publicly traded biotechnology company, is focused on the development of novel therapeutics to prevent and treat heart disease. The Company was formed through the November 2013 merger between Capricor, Inc., a privately held company whose mission is to improve the treatment of heart disease by commercializing cardiac st...

GLEN RESEARCH

GLen research Corporation-FOUNDED TO PROVIDE REAGENTS AND SERVICES FOR DNA RESEARCH BASED ON TECHNICAL EXCELLENCE AND WITH QUALITY ASSURED.The Glen Research concept was based on our perception that the research community required a supply of novel reagents which, at first glance, may have seemed of little commercial value to the larger suppliers. We saw these esoteric products as the potential veh...

Centrexion Therapeutics Corp.

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest, exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims to de...

Akarna Therapeutics Ltd.

Akarna Therapeutics is a privately held biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment. Akarna’s lead program is a potential best-in-class FXR agonist for the treatment of non-alcoholic steatohepatitis (NASH). Akarna’s lead candidate is ...

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT). As first application of RPT SCT Spinal Cord Therapeutics GmbH is focusing on the clinical development of the Orphan Drug Cordaneurin for the treatment of acute SCI.

MDReview

MDReview provides highly effective and innovative physician peer review, delivered with the utmost integrity. MDReview’s main purpose is to support hospitals in making some of the most important decisions that are at the heart of their quality management efforts. With a national reach to a diverse client base in all 50 state, MDReview is the standard ...

Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, is currently being evaluated in a Phase III clinical development program. For more information, please visit www.soleno.life.

Centrexion Therapeutics, Corp.

Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion patients living with chronic pain worldwide, and ...

Centrexion Therapeutics Corporation

Centrexion Therapeutics Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of non-opioid, non-addictive therapies in active development. Centrexion Therapeutics recognizes the needs of over a quarter of a billion people living with chronic pain worldwide, and aims ...

BBB Therapeutics

BBB Therapeutics is pioneering innovative therapeutics to treat severe brain disorders for which there are currently limited treatment options. We are advancing a clinical pipeline of product candidates initially focused on treating brain metastases and primary brain tumors as well as indications in neuroinflammation. Our proprietary liposomal G-Technology...

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Therapeutics pioneers intelligent cancer therapies that are scientifically tailored for each individual patient. What do we do?Rational Therapeutics develops and provides cancer therapy recommendations,...

CV Therapeutics, Inc.

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases. CV Therapeutics Europe Ltd. is the company's European subsidiary based in the United Kingdom.

Advarra

Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research ...

Makefield Therapeutics, Inc.

Makefield Therapeutics, Inc., founded in July 2009, is a privately held therapeutics company with two development programs addressing large market opportunities in anti-infectives and the treatment of erectile dysfunction. Both programs are based on an innovative nanoparticle drug delivery platform with the potential to generate a pipeline of additional no...

Priority Metrics Group

Priority Metrics Group, Inc. (PMG), Spartanburg, S.C, is a professional marketing consulting firm with 20-plus years of experience. The company provides customized research, analysis and consulting services designed to generate profitable growth for its clients. PMG works with leading organizations around the world in a variety of manufacturing and service ...


More From BioPortfolio on "Acer Therapeutics Announces Acceptance Priority Review EDSIVO Treatment"

Quick Search

Corporate Database Quicklinks